Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma (Protocol-A)

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

OHSU Knight Cancer Institute

ClinicalTrials.gov Identifier:

NCT00074191

First received: December 10, 2003

Last updated: May 24, 2012

Last verified: February 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2000
Primary Completion Date:	October 2000 (Final data collection date for primary outcome measure)